R. Ruediger et al., Disruption of protein phosphatase 2A subunit interaction in human cancers with mutations in the A alpha subunit gene, ONCOGENE, 20(1), 2001, pp. 10-15
The A subunit of protein phosphatase 2A (PP2A) consists of 15 nonidentical
repeats. The catalytic C subunit binds to C-terminal repeats 11-15 and regu
latory B subunits bind to N-terminal repeats 1-10, Recently, four cancer-as
sociated mutants of the A alpha subunit have been described: Glu64-->Asp in
lung carcinoma, Glu64 --> Gly in breast carcinoma, Arg418 --> Trp in melan
oma, and Delta 171-589 in breast carcinoma, Based on our model of PP2A, we
predicted that Glu64-->Asp and Glu64-->Gly might be defective in B subunit
binding, whereas Arg418-->Trp and Delta 171 - 589 might bind neither B nor
C subunits, We generated these mutants by site-directed mutagenesis and ass
ayed their ability to associate with different forms of B subunits (B, B',
B") or with the catalytic C subunit, The results demonstrate that all mutan
ts are defective in binding either B or B and C subunits, Specifically, the
N-terminal mutants, Glu64-->Asp and Glu64-->Gly, are defective in B' but n
ormal in B, B", and C subunit binding, whereas the C-terminal mutants Arg41
8-->Trp and Delta 171-589 bind none of the B subunits nor the C subunit, Th
e implications of these findings with regard to the potential role of PP2A
as a tumor suppressor are discussed.